Metabolic Syndrome With Aortic Arterial Stiffness And First Hospitalization Or Mortality In Coronary Artery Disease Patients

References

• Trayhurn P , Wood IS . Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr . 2004;92:347–355. doi:10.1079/bjn20041213 15469638
   PubMed Web of Science ®Google Scholar
• Rosenson RS . Assessing risk across the spectrum of patients with the metabolic syndrome. Am J Cardiol . 2005;96:8E–10E. doi:10.1016/j.amjcard.2005.05.007
   Web of Science ®Google Scholar
• Licata G , Tuttolomondo A , Corrao S , et al. Immunoinflammatory activation during the acute phase of lacunar and non-lacunar ischemic stroke: association with time of onset and diabetic state. Int J Immunopathol Pharmacol . 2006;19:639–646. doi:10.1177/039463200601900320 17026849
   PubMed Web of Science ®Google Scholar
• Tuttolomondo A , Di Sciacca R , Di Raimondo D , et al. Effects of clinical and laboratory variables and of pretreatment with cardiovascular drugs in acute ischaemic stroke: a retrospective chart review from the GIFA study. Int J Cardiol . 2011;151:318–322. doi:10.1016/j.ijcard.2010.06.005 20598761
   PubMed Web of Science ®Google Scholar
• Di Raimondo D , Tuttolomondo A , Buttà C , et al. Effects of ACE-inhibitors and angiotensin receptor blockers on inflammation. Curr Pharm Des . 2012;18:4385–4413. doi:10.2174/138161212802481282 22283779
   PubMed Web of Science ®Google Scholar
• Sattar N , Gaw A , Scherbakova O , et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation . 2003;108:414–419. doi:10.1161/01.CIR.0000080897.52664.94 12860911
   PubMed Web of Science ®Google Scholar
• Lakka HM , Laaksonen DE , Lakka TA , et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA . 2002;288:2709–2716. doi:10.1001/jama.288.21.2709 12460094
   PubMed Web of Science ®Google Scholar
• Malik S , Wong ND , Franklin SS , et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation . 2004;110:1245–1250. doi:10.1161/01.CIR.0000140677.20606.0E 15326067
   PubMed Web of Science ®Google Scholar
• Vlachopoulos C , Aznaouridis K , Stefanadis C . Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol . 2010;55:1318–1327. doi:10.1016/j.jacc.2009.10.061 20338492
   PubMed Web of Science ®Google Scholar
• Nam HJ , Jung IH , Kim J , et al. Association between brachial-ankle pulse wave velocity and occult coronary artery disease detected by multi-detector computed tomography. Int J Cardiol . 2012;157:227–232. doi:10.1016/j.ijcard.2011.01.045 21315465
   PubMed Web of Science ®Google Scholar
• Kullo IJ , Bielak LF , Turner ST , Sheedy PF , Peyser PA . Aortic pulse wave velocity is associated with the presence and quantity of coronary artery calcium: a community-based study. Hypertension . 2006;47:174–179. doi:10.1161/01.HYP.0000199605.35173.14 16380523
   PubMed Web of Science ®Google Scholar
• Gong J , Xie Q , Han Y , et al. Relationship between components of metabolic syndrome and arterial stiffness in Chinese hypertensives. Clin Exp Hypertens . 2019;1–7. doi:10.1080/10641963.2019.1590385
   Web of Science ®Google Scholar
• Levisianou D , Melidonis A , Adamopoulou E , et al. Impact of the metabolic syndrome and its components combinations on arterial stiffness in Type 2 diabetic men. Int Angiol . 2009;28:490–495.20087288
   PubMed Web of Science ®Google Scholar
• Nichols GA , Moler EJ . Metabolic syndrome components are associated with future medical costs independent of cardiovascular hospitalization and incident diabetes. Metab Syndr Relat Disord . 2011;9:127–133. doi:10.1089/met.2010.0105 21166586
   PubMed Web of Science ®Google Scholar
• Mancia G , Fagard R , Narkiewicz K , et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens . 2013;31:1281–1357. doi:10.1097/01.hjh.0000431740.32696.cc 23817082
   PubMed Web of Science ®Google Scholar
• Tsai JP , Wang JH , Chen ML , et al. Association of serum leptin levels with central arterial stiffness in coronary artery disease patients. BMC Cardiovasc Disord . 2016;16:80. doi:10.1186/s12872-016-0371-7 27151106
   PubMed Web of Science ®Google Scholar
• Chen MC , Lee CJ , Yang CF , et al. Low serum adiponectin level is associated with metabolic syndrome and is an independent marker of peripheral arterial stiffness in hypertensive patients. Diabetol Metab Syndr . 2017;9:49. doi:10.1186/s13098-017-0247-8 28670347
   PubMed Web of Science ®Google Scholar
• Wang JH , Lee CJ , Yang CF , et al. Serum resistin as an independent marker of aortic stiffness in patients with coronary artery disease. PLoS One . 2017;12:e0183123. doi:10.1371/journal.pone.0183123 28806778
   PubMed Web of Science ®Google Scholar
• Alberti KG , Zimmet P , Shaw J . Metabolic syndrome–a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med . 2006;23:469–480. doi:10.1111/j.1464-5491.2006.01858.x 16681555
   PubMed Web of Science ®Google Scholar
• Laurent S , Boutouyrie P . Arterial stiffness: a new surrogate end point for cardiovascular disease? J Nephrol . 2007;20 Suppl 12:S45–S50.18050143
   PubMed Web of Science ®Google Scholar
• Palombo C , Kozakova M . Arterial stiffness, atherosclerosis and cardiovascular risk: pathophysiologic mechanisms and emerging clinical indications. Vascul Pharmacol . 2016;77:1–7. doi:10.1016/j.vph.2015.11.083 26643779
   PubMed Web of Science ®Google Scholar
• Moreira GC , Cipullo JP , Ciorlia LA , et al. Prevalence of metabolic syndrome: association with risk factors and cardiovascular complicationss in an urban population. PLoS One . 2014;9:e105056. doi:10.1371/journal.pone.0105056 25180496
   PubMed Web of Science ®Google Scholar
• Ramirez AJ , Christen AI , Sanchez RA . Serum uric acid elevation is associated to arterial stiffness in hypertensive patients with metabolic disturbances. Curr Hypertens Rev . 2018;14:154–160. doi:10.2174/1573402114666180413143312 29651957
   PubMed Web of Science ®Google Scholar
• Cecelja M , Chowienczyk P . Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension . 2009;54:1328–1336. doi:10.1161/HYPERTENSIONAHA.109.137653 19884567
   PubMed Web of Science ®Google Scholar
• Schram MT , Henry RM , van Dijk RA , et al. Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study. Hypertension . 2004;43:176–181. doi:10.1161/01.HYP.0000111829.46090.92 14698999
   PubMed Web of Science ®Google Scholar
• Agnoletti D , Mansour AS , Zhang Y , et al. Clinical interaction between diabetes duration and aortic stiffness in type 2 diabetes mellitus. J Hum Hypertens . 2017;31:189–194. doi:10.1038/jhh.2016.58 27604661
   PubMed Web of Science ®Google Scholar
• Brunner EJ , Shipley MJ , Ahmadi-Abhari S , et al. Adiposity, obesity, and arterial aging: longitudinal study of aortic stiffness in the Whitehall II cohort. Hypertension . 2015;66:294–300. doi:10.1161/HYPERTENSIONAHA.115.05494 26056335
   PubMed Web of Science ®Google Scholar
• Yun BH , Chon SJ , Cho SH , et al. Decreased renal function is a risk factor for subclinical coronary atherosclerosis in Korean postmenopausal women. J Menopausal Med . 2016;22:167–173. doi:10.6118/jmm.2016.22.3.167 28119897
   PubMedGoogle Scholar
• Ilyas B , Dhaun N , Markie D , et al. Renal function is associated with arterial stiffness and predicts outcome in patients with coronary artery disease. QJM . 2009;102:183–191. doi:10.1093/qjmed/hcn171 19129249
   PubMed Web of Science ®Google Scholar
• Ford ML , Tomlinson LA , Chapman TP , Rajkumar C , Holt SG . Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4. Hypertension . 2010;55:1110–1115. doi:10.1161/HYPERTENSIONAHA.109.143024 20212269
   PubMed Web of Science ®Google Scholar
• Karras A , Haymann JP , Bozec E , et al. Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease. Hypertension . 2012;60:1451–1457. doi:10.1161/HYPERTENSIONAHA.112.197210 23090769
   PubMed Web of Science ®Google Scholar
• Zoungas S , Cameron JD , Kerr PG , et al. Association of carotid intima-medial thickness and indices of arterial stiffness with cardiovascular disease outcomes in CKD. Am J Kidney Dis . 2007;50:622–630. doi:10.1053/j.ajkd.2007.07.012 17900462
   PubMed Web of Science ®Google Scholar
• Sipila K , Koivistoinen T , Moilanen L , et al. Metabolic syndrome and arterial stiffness: the Health 2000 Survey. Metabolism . 2007;56:320–326. doi:10.1016/j.metabol.2006.10.008 17292719
   PubMed Web of Science ®Google Scholar
• Yokoyama H , Kuramitsu M , Kanno S , Tada J , Yokota Y , Kamikawa F . Relationship between metabolic syndrome components and vascular properties in Japanese type 2 diabetic patients without cardiovascular disease or nephropathy. Diabetes Res Clin Pract . 2007;75:200–206. doi:10.1016/j.diabres.2006.06.015 16860430
   PubMed Web of Science ®Google Scholar